Botulinum Toxin Injections
J15 · Effective Feb 22, 2026
164 active Medicare policies list G35.A, and 13 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
Showing 100 of 164
J15 · Effective Feb 22, 2026
J6 · Effective Feb 22, 2026
JK · Effective Feb 22, 2026
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
JJ · Effective Feb 22, 2026
JM · Effective Feb 22, 2026
J5 · Effective Feb 22, 2026
J5
J8 · Effective Feb 22, 2026
13 policies from 3 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of G35.A |
|---|---|---|
| Blood-based Biomarker Tests for Multiple Sclerosis | Oct 1, 2026 | Not covered |
| Fundus Photography | Apr 15, 2026 | Covered |
| Hematopoietic Stem Cell Transplantation for Autoimmune Disease and Miscellaneous Solid Tumors | Jul 1, 2026 | Covered |
| Mechanical Insufflation-Exsufflation Devices | Jul 1, 2026 | Covered |
| Therapeutic Apheresis | Apr 15, 2026 | Covered |
| Therapeutic use of Stem Cells, Blood and Bone Marrow Products |
J8
J5 · Effective Sep 16, 2017
J8 · Effective Sep 16, 2017
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J9 · Effective Oct 1, 2015
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
J5 · Effective Oct 1, 2015
J8 · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J15 · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
JE · Effective Oct 8, 2018
JF · Effective Oct 8, 2018
J15 · Effective Oct 1, 2015
J9 · Effective Oct 1, 2015
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
JE · Effective Jun 1, 2016
JF · Effective Jun 1, 2016
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J5 · Effective Oct 1, 2015
J8 · Effective Oct 1, 2015
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
J6 · Effective Nov 1, 2022
JK · Effective Nov 1, 2022
J15 · Effective Aug 8, 2021
J6 · Effective Nov 1, 2022
JK · Effective Nov 1, 2022
J15 · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J15 · Effective Oct 1, 2015
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
J5 · Effective Oct 1, 2015
J8 · Effective Oct 1, 2015
J6 · Effective Jul 13, 2025
JK · Effective Jul 13, 2025
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
J9 · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J9 · Effective Oct 1, 2015
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
JJ · Effective Jan 29, 2018
JM · Effective Jan 29, 2018
J15 · Effective Oct 1, 2015
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
J15 · Effective Oct 1, 2015
J9 · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J5 · Effective Oct 1, 2015
J8 · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J15 · Effective Oct 1, 2015
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
J6 · Effective Mar 16, 2017
JK · Effective Mar 16, 2017
J5 · Effective Jul 17, 2017
J8 · Effective Jul 17, 2017
J15 · Effective Oct 1, 2015
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
National · Effective Apr 9, 2026
| Oct 1, 2026 |
| Not covered |
| Thyroid Testing | Apr 15, 2026 | Covered |
|---|
| Visual, Somatosensory and Motor Evoked Potentials | Apr 15, 2026 | Covered |
|---|
| Vitamin D Testing | Oct 1, 2026 | Covered |
|---|
| Policy | Effective | Status of G35.A |
|---|---|---|
| Airway Clearance Devices | Mar 1, 2026 | Covered |
| Briumvi (Ublituximab-Xiiy) | Jan 1, 2026 | Covered |
| Lemtrada (Alemtuzumab) | Apr 1, 2026 | Covered |
| Policy | Effective | Status of G35.A |
|---|---|---|
| Pharmacogenetic Testing | Jul 15, 2026 | Covered |